Daymark Wealth Partners LLC Has $292,000 Holdings in The Clorox Company (NYSE:CLX)

Daymark Wealth Partners LLC grew its position in The Clorox Company (NYSE:CLX) by 56.6% in the 2nd quarter, HoldingsChannel.com reports. The institutional investor owned 2,136 shares of the company’s stock after purchasing an additional 772 shares during the period. Daymark Wealth Partners LLC’s holdings in Clorox were worth $292,000 at the end of the most recent quarter.

Other institutional investors have also made changes to their positions in the company. Core Wealth Advisors Inc. purchased a new position in Clorox during the 4th quarter worth approximately $29,000. Innealta Capital LLC purchased a new stake in shares of Clorox in the second quarter valued at $30,000. Trifecta Capital Advisors LLC boosted its position in shares of Clorox by 139.8% in the second quarter. Trifecta Capital Advisors LLC now owns 223 shares of the company’s stock worth $30,000 after buying an additional 130 shares during the period. GoalVest Advisory LLC purchased a new position in shares of Clorox during the first quarter valued at $31,000. Finally, First Foundation Advisors acquired a new position in Clorox during the first quarter valued at $31,000. 78.53% of the stock is owned by hedge funds and other institutional investors.

Clorox Stock Up 0.9 %

CLX opened at $163.42 on Friday. The Clorox Company has a twelve month low of $114.68 and a twelve month high of $169.09. The company has a debt-to-equity ratio of 5.04, a quick ratio of 0.63 and a current ratio of 1.03. The business has a 50 day moving average price of $151.92 and a 200 day moving average price of $144.05. The firm has a market cap of $20.29 billion, a P/E ratio of 84.67, a price-to-earnings-growth ratio of 3.31 and a beta of 0.40.

Clorox (NYSE:CLX) last issued its quarterly earnings data on Thursday, August 1st. The company reported $1.82 earnings per share for the quarter, topping analysts’ consensus estimates of $1.54 by $0.28. Clorox had a net margin of 3.95% and a return on equity of 281.12%. The business had revenue of $1.90 billion during the quarter, compared to analysts’ expectations of $1.97 billion. Research analysts forecast that The Clorox Company will post 6.63 EPS for the current year.

Clorox Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Thursday, November 7th. Stockholders of record on Wednesday, October 23rd will be paid a $1.22 dividend. The ex-dividend date is Wednesday, October 23rd. This represents a $4.88 dividend on an annualized basis and a dividend yield of 2.99%. Clorox’s payout ratio is presently 252.85%.

Insider Buying and Selling

In other Clorox news, EVP Angela C. Hilt sold 1,733 shares of the firm’s stock in a transaction that occurred on Friday, September 6th. The stock was sold at an average price of $165.52, for a total value of $286,846.16. Following the sale, the executive vice president now owns 13,471 shares of the company’s stock, valued at approximately $2,229,719.92. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is accessible through this link. 0.51% of the stock is owned by insiders.

Analyst Ratings Changes

A number of equities research analysts have commented on CLX shares. DA Davidson restated a “neutral” rating and set a $153.00 price objective on shares of Clorox in a research report on Friday, September 6th. Wells Fargo & Company decreased their price target on shares of Clorox from $135.00 to $130.00 and set an “underweight” rating for the company in a report on Wednesday, July 10th. JPMorgan Chase & Co. dropped their price objective on shares of Clorox from $150.00 to $148.00 and set a “neutral” rating on the stock in a research note on Friday, August 2nd. Deutsche Bank Aktiengesellschaft increased their target price on shares of Clorox from $144.00 to $151.00 and gave the stock a “hold” rating in a research report on Friday, August 2nd. Finally, BNP Paribas upgraded shares of Clorox to a “strong sell” rating in a report on Friday, September 6th. Six research analysts have rated the stock with a sell rating and twelve have assigned a hold rating to the stock. Based on data from MarketBeat, the company currently has a consensus rating of “Hold” and an average price target of $143.33.

Clorox Profile

The Clorox Company manufactures and markets consumer and professional products worldwide. It operates through four segments: Health and Wellness, Household, Lifestyle, and International. The Health and Wellness segment offers cleaning products, such as laundry additives and home care products primarily under the Clorox, Clorox2, Scentiva, Pine-Sol, Liquid-Plumr, Tilex, and Formula 409 brands; professional cleaning and disinfecting products under the CloroxPro and Clorox Healthcare brands; professional food service products under the Hidden Valley brand; and vitamins, minerals and supplement products under the RenewLife, Natural Vitality, NeoCell, and Rainbow Light brands in the United States.